Genedrive plc is a pioneering company in the field of near-patient molecular diagnostics. The company specializes in developing rapid and cost-effective diagnostic solutions that can be used at the point of need. Their core product is a molecular diagnostics platform designed for the identification and treatment selection of infectious diseases, human genotyping, animal health, and pathogen identification. This platform is particularly valuable in global health contexts where timely and accurate diagnostics are crucial.

Genedrive plc primarily serves healthcare providers, laboratories, and research institutions that require efficient and reliable diagnostic tools. The company operates in the global healthcare market, focusing on regions where access to centralized laboratory facilities is limited. Their business model revolves around the sale of diagnostic kits and software, as well as providing ongoing support and updates to their clients.

Revenue is generated through the direct sale of their diagnostic products, including the Genedrive 96 Exporter Software and the SARS CoV 2 Kit, which has received CE IVD Mark certification. Additionally, the company may engage in partnerships and collaborations to expand the reach and application of their technology.

Keywords: molecular diagnostics, infectious diseases, genotyping, pathogen identification, near-patient, rapid diagnostics, low-cost, healthcare, global health, CE IVD Mark.